Literature DB >> 36100701

Reply to: association between stress hyperglycemia on admission and unfavorable neurological outcome in OHCA patients receiving ECPR (https://doi.org/10.1007/s00392-022-02057-4).

Xavier Bemtgen1, Tobias Wengenmayer2, Dawid L Staudacher2.   

Abstract

Entities:  

Year:  2022        PMID： 36100701     DOI： 10.1007/s00392-022-02097-w

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   6.138


× No keyword cloud information.
  5 in total

1.  The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock - Results from the CardShock Study.

Authors:  Anu Kataja; Tuukka Tarvasmäki; Johan Lassus; Jose Cardoso; Alexandre Mebazaa; Lars Køber; Alessandro Sionis; Jindrich Spinar; Valentina Carubelli; Marek Banaszewski; Rossella Marino; John Parissis; Markku S Nieminen; Veli-Pekka Harjola
Journal:  Int J Cardiol       Date:  2016-10-17       Impact factor: 4.164

Review 2.  Hypoglycemic brain damage.

Authors:  Roland N Auer
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

3.  Association between stress hyperglycemia on admission and unfavorable neurological outcome in OHCA patients receiving ECPR.

Authors:  Takuya Taira; Akihiko Inoue; Takeshi Nishimura; Ryo Takahashi; Maho Isobe; Saki Maemura; Masafumi Suga; Shinichi Ijuin; Tomoya Masano; Shigenari Matsuyama; Satoshi Ishihara; Yasuhiro Kuroda; Shinichi Nakayama
Journal:  Clin Res Cardiol       Date:  2022-07-08       Impact factor: 6.138

Review 4.  Sugar for the brain: the role of glucose in physiological and pathological brain function.

Authors:  Philipp Mergenthaler; Ute Lindauer; Gerald A Dienel; Andreas Meisel
Journal:  Trends Neurosci       Date:  2013-08-20       Impact factor: 13.837

5.  Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenation.

Authors:  Xavier Bemtgen; Jonathan Rilinger; Markus Jäckel; Viviane Zotzmann; Alexander Supady; Christoph Benk; Christoph Bode; Tobias Wengenmayer; Achim Lother; Dawid L Staudacher
Journal:  Clin Res Cardiol       Date:  2021-05-04       Impact factor: 5.460
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.